Corvia Medical, Inc., is dedicated to revolutionizing the treatment of heart failure with first-in-class structural heart devices. The company has developed the world’s first transcatheter device designed to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF), ejection fraction, previously known as diastolic heart failure (DHF). The innovative InterAtrial Shunt Device (IASD®) is designed to reduce elevated left atrial pressure (LAp), which is the main cause of heart failure symptoms.
Corvia Medical is enrolling patients in the REDUCE LAP HF II Study. To learn more, visit treatmyheartfailure.com.
Patients Eager to Test Device That Could Ease Heart Failure Symptoms
Ohio State Evaluates First Transcatheter Implant for Diastolic Heart Failure